Company: GSHRW
Filing Date: 2025-02-27
Form Type: S-1/A
Source: 0001213900-25-018139
Chunk: 155

Company: Gesher Acquisition Corp. II
Filing Date: 2025-02-27
Form: S-1/A
Chunk 155
---

101 combination occurs or for general corporate purposes, including payment of principal or interest on indebtedness incurred in connection with our initial business combination, to fund the purchases of other companies, or for working capital. The underwriters will not be entitled to any interest accrued on the deferred underwriting discounts and commissions. (4)These expenses are estimates only. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and accounting expenses than our current estimates in connection with negotiating and structuring our initial business combination based upon the level of complexity of such business combination. In the event we identify a business combination target in a specific industry subject to specific regulations, we may incur additional expenses associated with legal due diligence and the engagement of special legal counsel. In addition, our staffing needs may vary and as a result, we may engage a number of consultants to assist with legal and financial due diligence. We do not anticipate any change in our intended use of proceeds, other than fluctuations among the current categories of allocated expenses, which fluctuations, to the extent they exceed current estimates for any specific category of expenses, would not be available for our expenses. The amount in the table above does not include interest available to us from the trust account. (5)Reflects first year of payments for office space and administrative support. Nasdaq rules provide that at least 90% of the gross proceeds from this offering and the sale of the private placement units be deposited in a trust account. Of the $130,225,000 in gross proceeds we receive from this offering and the sale of the private placement units described in this prospectus, or $149,406,250 if the underwriters’ over -allotmentoption is exercised in full, $125,375,000 ($10.03 per unit), or $144,181,250 if the underwriters’ over -allotmentoption is exercised in full ($10.03 per unit), will be deposited into a trust account in the United States with Continental Stock Transfer & Trust Company acting as trustee, after deducting $2,500,000 in underwriting discounts and commissions payable upon the closing of this offering (or up to $2,875,000 if the underwriters’ over -allotmentoption is exercised in full) and an aggregate of $2,350,000 to pay fees and expenses in connection with the closing of this offering and for working capital following the closing of this offering. The proceeds held in the trust account